Switching azathioprine to mycophenolate mofetil reduces UVA photosensitivity of the skin and DNA 6-thioguanine in PBMC of kidney transplant recipients

被引：0
|
作者：
Hofbauer, Guenther F. L. [1 ]
Straub, Gilles [1 ]
Dziunycz, Piotr [1 ]
Meyer, Rafael [1 ]
Karran, Peter [2 ]
Attard, Natalie [2 ]
Kamenisch, York [3 ]
Berneburg, Mark [3 ]
French, Lars E. [1 ]
Wuethrich, Rudolf P. [4 ]
Serra, Andreas L. [4 ]
机构：
[1] Univ Zurich Hosp, Dept Dermatol, CH-8091 Zurich, Switzerland
[2] Imperial Canc Res Fund, Clare Hall Labs, Canc Res Inst, S Mimms EN6 3LD, Herts, England
[3] Univ Tubingen, Dept Dermatol, D-72074 Tubingen, Germany
[4] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2010年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：S63 / S63
页数：1
相关论文
共 15 条
  • [1] SWITCHING AZATHIOPRINE TO MYCOPHENOLATE MOFETIL REDUCES SKIN UVA PHOTOSENSITIVITY AND WHITE CELL DNA 6-THIOGUANINE LEVELS IN RENAL TRANSPLANT RECIPIENTS
    Hofbauer, Gunther F.
    Straub, Gilles
    Meyer, Robert
    Karran, Peter
    Attard, Natalie
    French, Lars
    Wuthrich, Rudolf P.
    Serra, Andreas L.
    [J]. TRANSPLANT INTERNATIONAL, 2009, 22 : 8 - 8
  • [2] Switching azathioprine to mycophenolate reduces UVA photosensitivity in renal transplant recipients
    Hofbauer, G.
    Straub, G.
    Meyer, R.
    Karran, P.
    Attard, N.
    French, L.
    Wuethrich, R.
    Serra, A.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 : S16 - S16
  • [3] Reversal of UVA Skin Photosensitivity and DNA Damage in Kidney Transplant Recipients by Replacing Azathioprine
    Hofbauer, G. F. L.
    Attard, N. R.
    Harwood, C. A.
    McGregor, J. M.
    Dziunycz, P.
    Iotzova-Weiss, G.
    Straub, G.
    Meyer, R.
    Kamenisch, Y.
    Berneburg, M.
    French, L. E.
    Wuethrich, R. P.
    Karran, P.
    Serra, A. L.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (01) : 218 - 225
  • [4] Association of Skin Cancer With the Use of Azathioprine And Mycophenolate Mofetil in Kidney Transplant Recipients
    Ali, Hatem
    Briggs, David
    Krishnan, Nithya
    [J]. TRANSPLANTATION, 2022, 106 (09) : S406 - S406
  • [5] Should 6-thioguanine nucleotides be monitored in heart transplant recipients given azathioprine?
    Schutz, E
    Gummert, J
    Mohr, FW
    Armstrong, VW
    Oellerich, M
    [J]. THERAPEUTIC DRUG MONITORING, 1996, 18 (03) : 228 - 233
  • [6] Mycophenolate Mofetil and the Incidence of Skin Cancer in Kidney Transplant Recipients
    Yusuf, S. J.
    Bheemreddy, H.
    Imtiaz, A.
    Krishnan, N.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 831 - 831
  • [7] MYCOPHENOLATE MOFETIL AND THE INCIDENCE OF SKIN CANCER IN KIDNEY TRANSPLANT RECIPIENTS
    Yusuf, Sarah
    Bheemreddy, Himaja
    Ahmed, Imtiaz
    Krishnan, Nithya
    [J]. TRANSPLANTATION, 2020, 104 (09) : S603 - S603
  • [8] Pharmacometabolomics identified nonactivated metabolites of azathioprine and mycophenolate mofetil in urine of kidney transplant recipients
    Klont, Frank
    Bakker, Stephan J. L.
    Hak, Eelko
    Touw, Daan J.
    Hopfgartner, Gerard
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1616 - I1616
  • [9] Mycophenolate mofetil versus azathioprine in simultaneous pancreas-kidney transplant recipients on cyclosporine
    Fabrega, AJ
    Corwin, CL
    Hunsicker, L
    [J]. TRANSPLANTATION PROCEEDINGS, 1998, 30 (04) : 1562 - 1563
  • [10] Safe conversion of mycophenolate mofetil to azathioprine in kidney transplant recipients with sirolimus-based immunosuppression
    El-Agroudy, Amgad E.
    El-Dahshan, Khaled F.
    Wafa, Ehab W.
    Sheashaa, Hussien A.
    Gad, Ziad A.
    Ismail, Amani M.
    Shokeir, Ahmed A.
    Ghoneim, Mohamed A.
    [J]. NEPHROLOGY, 2009, 14 (02) : 255 - 261
12